[
  {
    "ts": "2025-12-10T15:33:10+00:00",
    "headline": "Wall Street Outlook For Elevance Health, Inc. (ELV) Supported By Prior TD Cowen Upgrade",
    "summary": "Elevance Health, Inc. (NYSE:ELV) is among the cheap healthcare stocks to buy heading into 2026. As of December 7, Elevance Health, Inc. (NYSE:ELV) has a ‘Buy’ or equivalent rating from slightly more than half of the analysts covering the stock. With a median price target of $394, the stock has an upside potential of 19.12%. […]",
    "url": "https://finance.yahoo.com/news/wall-street-outlook-elevance-health-153310529.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "dacd93cb-12bc-3c9c-ad82-2ab021b71520",
      "content": {
        "id": "dacd93cb-12bc-3c9c-ad82-2ab021b71520",
        "contentType": "STORY",
        "title": "Wall Street Outlook For Elevance Health, Inc. (ELV) Supported By Prior TD Cowen Upgrade",
        "description": "",
        "summary": "Elevance Health, Inc. (NYSE:ELV) is among the cheap healthcare stocks to buy heading into 2026. As of December 7, Elevance Health, Inc. (NYSE:ELV) has a ‘Buy’ or equivalent rating from slightly more than half of the analysts covering the stock. With a median price target of $394, the stock has an upside potential of 19.12%. […]",
        "pubDate": "2025-12-10T15:33:10Z",
        "displayTime": "2025-12-10T15:33:10Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/eadec32765d79f6cf3279c2d18e4f869",
          "originalWidth": 1000,
          "originalHeight": 667,
          "caption": "Healthcare Careers That Require a Master’s Degree",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Gh6wLdleoZtsA7dheS6sSw--~B/aD02Njc7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/eadec32765d79f6cf3279c2d18e4f869.cf.webp",
              "width": 1000,
              "height": 667,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/wTll.utFWyhJyxauvm9oEA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/eadec32765d79f6cf3279c2d18e4f869.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/wall-street-outlook-elevance-health-153310529.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/wall-street-outlook-elevance-health-153310529.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ELV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]